Review
Copyright ©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 166-186
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Table 1 Success rate and complications for percutaneous transhepatic biliary drainage, endoscopic ultrasound-guided biliary drainage, endoscopic retrograde cholangiopancreatography and self-expandable metal stent
Ref.
Procedure
Patients, n
Technical success %
Morbidity %
Artifon et al[50], 2012 PTBD, EUS-BD12, 13100, 10025.00, 15.30
Bapaye et al[51], 2013PTBD, EUS-BD26, 2546.00, 92.0046.00, 20.00
Khashab et al[52], 2015PTBD, EUS-BD 51, 22100, 86.4039.20, 18.20
Dhir et al[53], 2015ERCP SEMS, EUS-BD104, 10494.23, 93.268.65, 8.65
Table 2 Meta-analyses comparing self-expandable metal stents with plastic stents for the endoscopic drainage of distal malignant biliary obstruction
Ref.
Studies included
Patients, n
Procedures
Results
Almadi et al[62], 201720 1713Endoscopic or percutaneous palliative biliary drainage with plastic stent vs SEMSStent patency 4.45 mo (95%CI: 0.31-8.59) in favor of SEMS; Overall survival 0.67 (95%CI: 0.66-1.99), no difference
Moole et al[33], 201711947Endoscopic palliative biliary drainage with plastic stent vs SEMSStent occlusion OR 0.48 (95%CI: 0.34-0.67) in favor of SEMS; Overall survival/time to death: (1) SEMS, 157.3 d (95%CI: 148.9-165.6), (2) Plastic, 120.6 d (95%CI: 114.3-126.9), P = 0.0024
Zorrón Pu et al[64], 2015131133Endoscopic palliative biliary drainage with plastic stent vs SEMSStent dysfunction, RD -0.26 (95%CI: -0.32 to -0.20) in favor of SEMS; Survival longer in the SEMS group (187 d vs 162 d, P < 0.0001)
Sawas et al[65], 2015191989Endoscopic or percutaneous palliative biliary drainage with plastic stent vs SEMSStent occlusion, HR 0.42 (95%CI: 0.27-0.64) in favor of SEMS; 30-d survival, HR 0.82 (95%CI: 0.45-1.48), no difference
Hong et al[66], 201310785Endoscopic palliative biliary drainage with plastic stent vs SEMSStent patency, HR 0.37 (95%CI: 0.28-0.48) in favor of SEMS; Survival, HR 0.81 (95%CI: 0.68-0.96) in favor of SEMS
Table 3 Photodynamic therapy in patients with cholangiocarcinoma
Ref.
No. patients
Median survival, d/mo
Adjuvant therapy
Ortner et al[106]PDT 20, Control 19493 d, 98 dPDT -, Control -
Zoepf et al[103]PDT 16, Control 16630 d, 210 dPDT -, Control -
Dumoulin et al[100]PDT 24, Control 239.9 mo, 5.6 moPDT -, Control -
Kahaleh et al[102]PDT 19, Control 218.0 mo, 5.0 moPDT, CTX 11; RTX 9; CTX 11, RTX 10
Witzigman et al[99]PDT 68, Control 5612.0 mo, 6.4 moPDT, CTX 6; RTX 2; CTX 5, RTX 1